← Leaderboards
Charles Muiruri
Duke University
$735,851
Attributed
$735,851
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $153.4K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$735,851 · 1
By mechanism
K01$735,851 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Frank Sloan$9,580,143
- Melanie C. Wright$1,562,395
- Rachel Glennerster$661,130
- Erica M Field$2,593,203
- Tamara J Somers$6,296,521
Others in their field
Other Emerging Leaders on “Dosage”
- Richard Scranton · Lyndra Therapeutics, Inc.$12,106,230
- Melissa Allard · Albany Molecular Research, Inc.$8,788,340
- Patrick Boen · Lyndra Therapeutics, Inc.$8,679,033
- Warren David Lo · Virginia Polytechnic Inst And St Univ$7,604,467
- Erin Rooney Riggs · Broad Institute, Inc.$6,471,349
- Montserrat C Anguera · University Of Pennsylvania$6,121,298
Research focus
DosageEconometricsAdherenceDecision MakingAcute Myocardial InfarctionDyslipidemiasAntiretroviral TherapyAwardCostBehavioralBehavior Change WheelBlood PressureDevelopment PlansDesignCardiovascular DiseasesCardiovascular Disorder PreventionCardiovascular Disorder RiskCardiovascular SystemCareer DevelopmentAchievementCaringClinicComorbidityEnrollment
Grant awards (5)
Addressing barriers to anti-hypertensive medication adherence among persons living who have achieved viral suppression$129,151
K01 · FY2025 · HL · contact PI
Addressing barriers to anti-hypertensive medication adherence among persons living who have achieved viral suppression$148,887
K01 · FY2024 · HL · contact PI
Addressing barriers to anti-hypertensive medication adherence among persons living who have achieved viral suppression$151,418
K01 · FY2023 · HL · contact PI
Addressing barriers to anti-hypertensive medication adherence among persons living who have achieved viral suppression$152,953
K01 · FY2022 · HL · contact PI
Addressing barriers to anti-hypertensive medication adherence among persons living who have achieved viral suppression$153,442
K01 · FY2021 · HL · contact PI